Cargando…
Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice
Obesity is associated with a cluster of metabolic disorders and systemic low-grade inflammation involving multiple organs. Recent findings have suggested that intestine is a key organ altered in response to high fat diet (HFD) feeding. Probiotics mainly lactobacillus strains have earlier been implic...
Autores principales: | Shang, Haixiao, Sun, Jia, Chen, Yong Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849746/ https://www.ncbi.nlm.nih.gov/pubmed/27123997 http://dx.doi.org/10.1371/journal.pone.0154373 |
Ejemplares similares
-
Clostridium butyricum CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells
por: Jia, Lingling, et al.
Publicado: (2017) -
Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice
por: Jia, Lingling, et al.
Publicado: (2017) -
Aerosol Inhalation of Heat-Killed Clostridium butyricum CGMCC0313-1 Alleviates Allergic Airway Inflammation in Mice
por: Li, Laodong, et al.
Publicado: (2022) -
Oral administration of Clostridium butyricum CGMCC0313-1 inhibits β-lactoglobulin-induced intestinal anaphylaxis in a mouse model of food allergy
por: Zhang, Juan, et al.
Publicado: (2017) -
Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation
por: Hagihara, Mao, et al.
Publicado: (2021)